What does Apotheek Vichte do?

Apotheek Vichte is a pharmacy in Anzegem. Private Limited, started on 26 January 1990, 2 establishments.

What is the address of Apotheek Vichte?

The registered office of Apotheek Vichte is located at Oudenaardestraat 4 box 1, 8570 Anzegem.

Is Apotheek Vichte still active?

Yes. According to the CBE (30 October 2026) Apotheek Vichte is active, legal situation “Normale toestand”, started on 26 January 1990.

Is Apotheek Vichte registered on Peppol?

Yes, Apotheek Vichte is registered on the Peppol network with ID 0208:0439917764.

What is the enterprise number of Apotheek Vichte?

The enterprise number of Apotheek Vichte is BE0439917764.

When was Apotheek Vichte founded?

Apotheek Vichte was founded on 26 January 1990.

Who are the directors of Apotheek Vichte?

According to the 2025 annual accounts, the directors of Apotheek Vichte are: CURISPHAR BV, CORTEXCO BV.

Is Apotheek Vichte a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 January 1990; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did Apotheek Vichte make in 2025?

Apotheek Vichte posted a profit after taxes of € 313,796 in financial year 2025.

What is the revenue of Apotheek Vichte?

As a small company, Apotheek Vichte is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 609,667.

How much does an employee at Apotheek Vichte earn?

The average wage cost per full-time employee at Apotheek Vichte was € 76,200 in 2025: staff costs of € 274,342 for 3.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Vichte have?

According to the 2025 annual accounts, Apotheek Vichte has 3.6 full-time equivalents (FTE).

Apotheek Vichte (Private Limited) - Anzegem

Dossier Apotheek Vichte, printed on 30 October 2026 from databakkes.be/en/0439917764/apotheek-vichte. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Vichte from Anzegem, company number BE0439917764, closed financial year 2025 with a result of € 313,796 after tax. For that financial year Apotheek Vichte recorded a gross margin of € 609,667 and equity of € 583,314. Compared with financial year 2024, the result moved from € 202,727 to € 313,796. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 583,314

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 313,796

▲ 55% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 366,995

▼ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 309,000 paid out

98 % of the profit went to the shareholders, mostly to CURISPHAR (50 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

3.6

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 274,342

▲ 8% vs 2024

€ 76,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 11,102

▲ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 210,766

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,333

▼ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 430,470 Gross margin 2022: € 430,470 First fiscal year in the series	€ 343,744 Gross margin 2023: € 343,744 ▼ 20% vs 2022 (€ 430,470) Unfavourable step	€ 479,446 Gross margin 2024: € 479,446 ▲ 39% vs 2023 (€ 343,744) Favourable step	€ 609,667 Gross margin 2025: € 609,667 ▲ 27% vs 2024 (€ 479,446) Favourable step	▲ 27%
Profit after taxes	€ 132,207 Profit after taxes 2022: € 132,207 First fiscal year in the series	€ 58,314 Profit after taxes 2023: € 58,314 ▼ 56% vs 2022 (€ 132,207) Unfavourable step	€ 202,727 Profit after taxes 2024: € 202,727 ▲ 248% vs 2023 (€ 58,314) Favourable step	€ 313,796 Profit after taxes 2025: € 313,796 ▲ 55% vs 2024 (€ 202,727) Favourable step	▲ 55%
Equity	€ 578,101 Equity 2022: € 578,101 First fiscal year in the series	€ 580,915 Equity 2023: € 580,915 Unchanged (€ 578,101) Favourable step	€ 582,642 Equity 2024: € 582,642 Unchanged (€ 580,915) Favourable step	€ 583,314 Equity 2025: € 583,314 Unchanged (€ 582,642) Favourable step
Total debts	€ 368,323 Total debts 2022: € 368,323 First fiscal year in the series	€ 422,220 Total debts 2023: € 422,220 ▲ 15% vs 2022 (€ 368,323) Unfavourable step	€ 502,919 Total debts 2024: € 502,919 ▲ 19% vs 2023 (€ 422,220) Unfavourable step	€ 552,718 Total debts 2025: € 552,718 ▲ 10% vs 2024 (€ 502,919) Unfavourable step	▲ 10%
Cash	€ 405,631 Cash 2022: € 405,631 First fiscal year in the series	€ 401,860 Cash 2023: € 401,860 ▼ 1% vs 2022 (€ 405,631) Unfavourable step	€ 393,181 Cash 2024: € 393,181 ▼ 2% vs 2023 (€ 401,860) Unfavourable step	€ 366,995 Cash 2025: € 366,995 ▼ 7% vs 2024 (€ 393,181) Unfavourable step	▼ 7%
Retained profit	€ 316,101 Retained profit 2022: € 316,101 First fiscal year in the series	€ 318,915 Retained profit 2023: € 318,915 ▲ 1% vs 2022 (€ 316,101) Favourable step	€ 320,642 Retained profit 2024: € 320,642 ▲ 1% vs 2023 (€ 318,915) Favourable step	€ 321,314 Retained profit 2025: € 321,314 Unchanged (€ 320,642) Favourable step
Dividend	€ 384,407 Dividend 2022: € 384,407 First fiscal year in the series	€ 55,500 Dividend 2023: € 55,500 ▼ 86% vs 2022 (€ 384,407) Unchanged	€ 201,000 Dividend 2024: € 201,000 ▲ 262% vs 2023 (€ 55,500) Unchanged	€ 309,000 Dividend 2025: € 309,000 ▲ 54% vs 2024 (€ 201,000) Unchanged	▲ 54%
Bank debt	€ 22,410 Bank debt 2022: € 22,410 First fiscal year in the series	€ 11,763 Bank debt 2023: € 11,763 ▼ 48% vs 2022 (€ 22,410) Favourable step	€ 913 Bank debt 2024: € 913 ▼ 92% vs 2023 (€ 11,763) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 913) Favourable step	▼ 100%
Balance sheet total	€ 946,424 Balance sheet total 2022: € 946,424 First fiscal year in the series	€ 1,003,135 Balance sheet total 2023: € 1,003,135 ▲ 6% vs 2022 (€ 946,424) Unchanged	€ 1,085,561 Balance sheet total 2024: € 1,085,561 ▲ 8% vs 2023 (€ 1,003,135) Unchanged	€ 1,136,032 Balance sheet total 2025: € 1,136,032 ▲ 5% vs 2024 (€ 1,085,561) Unchanged	▲ 5%
Employees (FTE)	4.2 Employees (FTE) 2022: 4.2 First fiscal year in the series	3.5 Employees (FTE) 2023: 3.5 ▼ 0.7 vs 2022 (4.2) Unchanged	3.5 Employees (FTE) 2024: 3.5 Unchanged (3.5) Unchanged	3.6 Employees (FTE) 2025: 3.6 ▲ 0.1 vs 2024 (3.5) Unchanged	▲ 0.1

Key figures of Apotheek Vichte, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Vichte?

What happened at Apotheek Vichte in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 313,796 (▲ 55% vs 2024). Source: NBB ↗
Dec 31, 2024 New establishment in Anzegem. KBO
Jun 8, 1990 New establishment in Anzegem. KBO
Jan 26, 1990 Start of the company according to the CBE. KBO

In short

From € 132,207 profit in 2022 to € 313,796 profit in 2025.

Paid € 19,973 in corporate taxes since 2022.

Best year ever: 2025, with € 313,796 profit.

On average € 169,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

CURISPHAR 50%

The stake of CURISPHAR comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Vichte

Behind Apotheek Vichte are CURISPHAR BV and CORTEXCO BV. The shares are held by CURISPHAR (50%).

Directors

According to the 2025 annual accounts

CURISPHAR BV

Director · represented by Vandenbussche Charlotte

CORTEXCO BV

Director · represented by Tack Eveline

Also active at: Apotheek De Klokkeput, PHARMA DMS, RCC PLAST, Westlaanapotheek, DERTIEN-ACHT

Shareholders

CURISPHAR

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Oudenaardestraat 4 box 1

8570 Anzegem

2.048.506.178

Oudenaardestraat 4/001

8570 Anzegem

Active since 8 June 1990

2.371.390.177

Klokketuin 75

8570 Anzegem

Active since 31 December 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0439.917.764

VAT number

BE 0439.917.764

Registered office

Oudenaardestraat 4 bus 1, 8570 Anzegem

Names & denominations

Apotheek Vichte

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 January 1990

Peppol

Active · Active since 9 Jul 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Vichte

Financials

What happened to Apotheek Vichte?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions